A
Ayr Wellness Inc
CNSX:AYR.A
Ayr Wellness Inc
CNSX:AYR.A
Price:
0.155
CAD
Market Closed
Market Cap:
CA$18.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Ayr Wellness Inc
CNSX:AYR.A
|
US |
|
D
|
Dioo Microcircuits Co Ltd Jiangsu
SSE:688381
|
CN |
|
T
|
Tiande Chemical Holdings Ltd
HKEX:609
|
HK |
|
Jiangsu Rainbow Heavy Industries Co Ltd
SZSE:002483
|
CN |
|
H
|
Hebei Jianxin Chemical Co Ltd
SZSE:300107
|
CN |
|
Keybridge Capital Ltd
ASX:KBC
|
AU |
|
Nipress Tbk PT
IDX:NIPS
|
ID |
|
Cdon AB
OTC:CDOAF
|
SE |
|
Preformed Line Products Co
NASDAQ:PLPC
|
US |
|
SSC Security Services Corp
XTSX:SECU
|
CA |
|
Aptorum Group Ltd
NASDAQ:APM
|
UK |
|
Soma Textiles & Industries Ltd
NSE:SOMATEX
|
IN |
|
B
|
Banco Pan SA
BOVESPA:BPAN4
|
BR |
|
Darkpulse Inc
OTC:DPLS
|
US |
|
Century Textiles and Industries Ltd
BSE:500040
|
IN |
|
T
|
Tian Teck Land Ltd
HKEX:266
|
HK |
|
C
|
Chinese Universe Publishing and Media Group Co Ltd
SSE:600373
|
CN |
|
Qingdao Eastsoft Communication Technology Co Ltd
SZSE:300183
|
CN |
|
S
|
S&S Tech Corp
KOSDAQ:101490
|
KR |
Relative Value
There is not enough data to reliably calculate the relative value of AYR.A.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AYR.A
Relative Value
Base Case
Not Available
Multiples Across Competitors
AYR.A Competitors Multiples
Ayr Wellness Inc Competitors
Ayr Wellness Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Ayr Wellness Inc
CNSX:AYR.A
|
18.1m CAD | 0 | -0 | 4.7 | -2.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 4.9 | 28.2 | 15.7 | 22.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.3 | 9.9 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
